Ya-Nan Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ya-Nan Wang has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Bin-Gui Wang
CAS and Shandong Province Key Laboratory of Experimental Marine Biology, Institute of Oceanology, Chinese Academy of Sciences, Nanhai Road 7, Qingdao 266071, China
1 shared publication - Ling-Hong Meng
CAS and Shandong Province Key Laboratory of Experimental Marine Biology Institute of Oceanology, Chinese Academy of Sciences Qingdao China
1 shared publication
Latest Publications
- Open Access
- 2 December 2020
- Published by MDPI AG in Marine Drugs
- Vol. 18 (12) , 614
Progress in Research on Bioactive Secondary Metabolites from Deep-Sea Derived Microorganisms
Deep sea has an extreme environment which leads to biodiversity of microorganisms and their unique physical and biochemical mechanisms. Deep-sea derived microorganisms are more likely to produce novel bioactive substances with special mechanism of action for drug discovery. This article reviews secondary metabolites with biological activities such as anti-tumor, anti-bacterial, anti-viral, and anti-inflammatory isolated from deep-sea fungi and bacteria during 2018–2020. Effective methods for screening and obtaining natural active compounds from deep-sea microorganisms are also summarized, including optimizing the culture conditions, using genome mining technology, biosynthesis and so on. The comprehensive application of these methods makes broader prospects for the development and application of deep sea microbial bioactive substances.
- 2 December 2020
- Published by MDPI AG in Marine Drugs
- Vol. 18 (12) , 614
Open AccessProgress in Research on Bioactive Secondary Metabolites from Deep-Sea Derived Microorganisms
Deep sea has an extreme environment which leads to biodiversity of microorganisms and their unique physical and biochemical mechanisms. Deep-sea derived microorganisms are more likely to produce novel bioactive substances with special mechanism of action for drug discovery. This article reviews secondary metabolites with biological activities such as anti-tumor, anti-bacterial, anti-viral, and anti-inflammatory isolated from deep-sea fungi and bacteria during 2018–2020. Effective methods for screening and obtaining natural active compounds from deep-sea microorganisms are also summarized, including optimizing the culture conditions, using genome mining technology, biosynthesis and so on. The comprehensive application of these methods makes broader prospects for the development and application of deep sea microbial bioactive substances.